Quinolynylmethylimidizoles as therapeutic agents

Details Quinolynylmethylimidizoles as therapeutic agents Quinolynylmethylimidizoles as therapeutic agents

2011-01-11

2011-01-11

Chung, Susannah (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S152000

Reexamination Certificate

active

07868020

ABSTRACT:
Disclosed herein is a compound of the formula (I):(I). Therapeutic methods, compositions and medicaments related thereto are also disclosed.

REFERENCES:
patent: 4814343 (1989-03-01), Cossement
patent: 5151526 (1992-09-01), Hsu et al.
patent: 6329369 (2001-12-01), Chow et al.
patent: 6465486 (2002-10-01), Baxter
patent: 6841684 (2005-01-01), Chow et al.
patent: 2002/0019390 (2002-02-01), Wong et al.
patent: 2003/0023098 (2003-01-01), Chow et al.
patent: 2006/0069144 (2006-03-01), Heidelbaugh
patent: 0 024 829 (1980-08-01), None
patent: 1 413 576 (1998-12-01), None
patent: WO 98/46572 (1998-10-01), None
patent: WO 99/28300 (1999-06-01), None
patent: WO 01/00586 (2001-01-01), None
patent: WO 02/076950 (2002-10-01), None
patent: WO 2006/036497 (2006-04-01), None
patent: WO 2006/036507 (2006-04-01), None
Prezeslawski R., et al.; “Synthesis and Alpha2-Adrenergic Activity of Quinoline and Quinoxaline Analogues of Medetomidine”; Proceedings of the Erdec Scientific Conference on Defense Research; Nov. 1994; pp. 121-127; XP008091151.
Seoung-Soo Hong et al.; “A Structure-Activity Relationship Study of Benzylic Modifications of 441 -(I -Naphthyl)ethyl]-1H-imidazoleos n al- and az-Adrenergic Receptors”; J. Med. Chem. 1994,37, 2328-2333.
Shilpa G. Lalchandani, et al; “Medetomidine analogs as selective agonists for the human a2-adrenoceptors”; Biochemical Pharmacology 67 (2004) 87-96.
D.D Miller, et al.; “Synthesis and biological Activity of a Series of Comformationally Restricted Analogs of 4-Substituted Imidazoles as a2-Adrenergic Agonists”; Proceedings of the Erdec Scientific Conference on Defense Research; Nov. 1994; pp. 113-119.
Yoshiya Amemiya et al.; “Medetomidine Analogs as a2-Adrenergic Agonists”; Egypt J. Pharm. Sci. 35, No. 1-6, pp. 403-410; 1994.
Yoshiya Amemiya et al.; “Synthesis and a-AdrenergicActivvities of 2- and 4-Substituted Imidazoline and Imidazole Analogues of α and β-Naphthalene”; Egypt J. Pharm. Sci. 35, No. 1-6, pp. 91-112; 1994.
B. V. Venkataraman et at.; “Structure-Activity Studies of New Imidazolines on Adrenoceptors of Rat Aorta and Puman Platelets”; Naunyn-Schmiedeberg's Arch Pharma, 344:454-463; 1994.

Affiliated with

Also associated with

Rating

Quinolynylmethylimidizoles as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinolynylmethylimidizoles as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolynylmethylimidizoles as therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2689395